LCI 1311
Pill imprint LCI 1311 has been identified as Terbutaline sulfate 5 mg.
Terbutaline is used in the treatment of premature labor; asthma, maintenance; asthma, acute and belongs to the drug classes adrenergic bronchodilators, tocolytic agents. There is no proven risk in humans during pregnancy.
Terbutaline 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Terbutaline sulfate Images
- Imprint:
-
LCI 1311
- Strength:
- 5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
lactose anhydrous
magnesium stearate
povidone
pregelatinized corn starch
- Drug Class:
- Adrenergic bronchodilators
Tocolytic agents - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1311
More Terbutaline Sulfate resources
- Terbutaline (Wolters Kluwer)
- Terbutaline Tablets (Wolters Kluwer)
- terbutaline (Cerner Multum)
- terbutaline inhalation (Cerner Multum)
- terbutaline (Micromedex) - Includes Dosage Information
- terbutaline Subcutaneous (Micromedex) - Includes Dosage Information
- Terbutaline Sulfate (AHFS DI)
- Terbutaline (FDA)
- Terbutaline Tablets (FDA)
- Terbutaline Sulfate (Wolters Kluwer)


